Introduction: Studies have shown that higher response levels can be obtained when the bone conduction stimulation position is closer to the cochlea. However, the morphological characteristics of round window niche and posterior tympanum in congenital aural atresia (CAA) and stenosis (CAS) patients were different from the normal. These affected the position of the cochlea at the cranial base. It was still unknown whether the distances from the cranium of CAA and CAS patients to the cochlea were the same as those of normal patients or not. Objective: To measure distances from various points on the lateral surface of the cranium to the cochlea and the cranium thickness on these points among a CAA group, CAS group and normal control group, which may provide valuable information for the better position of bone conduction stimulation. Methods: CT images of CAA, CAS patients and these patients’ healthy sides were analyzed. Firstly, the Frankfurt horizontal plane (Pfrkt) was established. Secondly, a model of part of the cranium was three-dimensionally reconstructed. Then, the Pfrkt plane was rotated down 20, 30 and 40° according to the superior margin of the external auditory canal. At every angle, points 25, 30, 35 and 40 mm away from the superior margin of the external auditory canal were marked out on the surface of the model and recorded as P20A, P30A, P40A, P20B, etc. The spatial distances between the cranium and ipsilateral cochlea were defined as lengths of points on the surface of the model to the cochlea apex (CA), cochlear base (CB) and modiolus midpoint (MM), respectively, recorded as P20A/CA, P20A/CB, P20A/MM, P30A/CA, etc. Results and Conclusions: In all groups, the length of P20D/CA was the shortest compared to P30D/CA and P40D/CA (p < 0.05). The P20A/CB and P20A/MM were also the shortest (p < 0.05). When the Pfrkt plane was rotated down 30 and 40°, the results were the same as at 20° (p < 0.05). However, P20D, P30D and P40D were almost on the mastoid air cells. We suggest that the bone conduction stimulation position is placed closer to the ear, while avoiding the mastoid air cells in the CAA and CAS patients.

1.
Kösling
S
,
Omenzetter
M
,
Bartel-Friedrich
S
.
Congenital malformations of the external and middle ear
.
Eur J Radiol
.
2009
Feb
;
69
(
2
):
269
79
.
[PubMed]
0720-048X
2.
Ishimoto
S
,
Ito
K
,
Karino
S
,
Takegoshi
H
,
Kaga
K
,
Yamasoba
T
.
Hearing levels in patients with microtia: correlation with temporal bone malformation.
LARYNGOSCOPE. 2007
2007
-
03
-
01
;117(3):461-65.
3.
Barillari
M
,
Cerini
R
,
Carner
M
,
Cacciatori
C
,
Spagnolli
F
,
Cardobi
N
, et al
Congenital aural atresia treated with floating mass transducer on the round window: 5 years of imaging experience. RADIOL MED. 2012
1990
-
04
-
01
;117(3):488-99.
4.
Colletti
V
,
Soli
SD
,
Carner
M
,
Colletti
L
.
Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window.
INT J AUDIOL. 2006
2006
-
10
-
01
;45(10):600-08.
5.
Colletti
L
,
Carner
M
,
Mandala
M
,
Veronese
S
,
Colletti
V
.
The floating mass transducer for external auditory canal and middle ear malformations.
OTOL NEUROTOL. 2011
2011
-
01
-
01
;32(1):108-15.
6.
Işeri
M
,
Orhan
KS
,
Kara
A
,
Durgut
M
,
Oztürk
M
,
Topdağ
M
, et al
A new transcutaneous bone anchored hearing device - the Baha® Attract System: the first experience in Turkey
.
Kulak Burun Bogaz Ihtis Derg
.
2014
Mar-Apr
;
24
(
2
):
59
64
.
[PubMed]
1300-7475
7.
Dun
CA
,
Faber
HT
,
de Wolf
MJ
,
Mylanus
EA
,
Cremers
CW
,
Hol
MK
. Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival. OTOL NEUROTOL. 2012
2012
-
02
-
01
;33(2):192-98.
8.
Wazen
JJ
,
Wycherly
B
,
Daugherty
J
.
Complications of bone-anchored hearing devices
.
Basel, Switzerland
:
Karger Publishers
;
2011
.
9.
Gawęcki
W
,
Stieler
OM
,
Balcerowiak
A
,
Komar
D
,
Gibasiewicz
R
,
Karlik
M
, et al
Surgical, functional and audiological evaluation of new Baha(®) Attract system implantations
.
Eur Arch Otorhinolaryngol
.
2016
Oct
;
273
(
10
):
3123
30
.
[PubMed]
0937-4477
10.
Dobrev
I
,
Stenfelt
S
,
Roosli
C
,
Bolt
L
,
Pfiffner
F
,
Gerig
R
, et al
Influence of stimulation position on the sensitivity for bone conduction hearing aids without skin penetration.
INT J AUDIOL. 2016
2016
-
08
-
01
;55(8):439-46.
11.
Stenfelt
S
,
Hakansson
B
,
Tjellstrom
A
. Vibration characteristics of bone conducted sound in vitro. J ACOUST SOC AM. 2000
2000
-
01
-
01
;107(1):422-31.
12.
Stenfelt
S
,
Goode
RL
. Transmission properties of bone conducted sound: measurements in cadaver heads. J ACOUST SOC AM. 2005
2005
-
10
-
01
;118(4):2373-91.
13.
Eeg-Olofsson
M
,
Stenfelt
S
,
Tjellstrom
A
,
Granstrom
G
.
Transmission of bone-conducted sound in the human skull measured by cochlear vibrations.
INT J AUDIOL. 2008
2008
-
12
-
01
;47(12):761-69.
14.
Chen
K
,
Yin
D
,
Lyu
H
,
Yang
L
,
Zhang
T
,
Dai
P
.
Anatomic measurements of the posterior tympanum related to the round window vibroplasty in congenital aural atresia and stenosis patients.
Acta Otolaryngol. 2016
2016
-
01
-
20
;136(5):470-74.
15.
Chen
K
,
Lyu
H
,
Xie
Y
,
Yang
L
,
Zhang
T
,
Dai
P.
Morphological Characteristics of Round Window Niche in Congenital Aural Atresia and Stenosis Patients. J Comput Assist Tomogr. 2015
2015
-
07
-
01
;39(4):547-51.
16.
Takegoshi
H
,
Kaga
K
.
Difference in facial canal anatomy in terms of severity of microtia and deformity of middle ear in patients with microtia.
LARYNGOSCOPE. 2003
2003
-
04
-
01
;113(4):635-39.
17.
Lee
ST
,
Mori
Y
,
Minami
K
,
An
CH
,
Park
JW
,
Kwon
TG
. Does skeletal surgery for asymmetric mandibular prognathism influence the soft tissue contour and thickness? J Oral Maxillofac Surg. 2013
2013
-
09
-
01
;71(9):1577-87.
18.
Reinfeldt
S
,
Hakansson
B
,
Taghavi
H
,
Eeg-Olofsson
M
.
Bone conduction hearing sensitivity in normal-hearing subjects: transcutaneous stimulation at BAHA vs BCI position.
INT J AUDIOL. 2014
2014
-
06
-
01
;53(6):360-69.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.